Solution reagent kit Qexp-MDx

diagnosticgeneticcoronavirus

BiOptic Inc. has been committed to the development of genetic testing solutions in recent years. Since the COVID-19 epidemic spread across the world, human life has been greatly affected. BiOptic Inc. base on the requirement of simplicity, affordability, and precision in order to maximize the effectiveness of genetic testing for COVID-19 prevention and make genetic testing closer to our lives Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the beta-coronavirus family, a group of single-positive-strand RNA viruses with envelopes. Coronavirus was named since its crown-like appearance observed under an electron microscope. They are infectious commonly between humans and animals. Currently, there are seven species known to infect humans: HCoV-229E, HCoV-NL63, HCoV-HKU1, HCoV-OC43, SARS-CoV, MERS-CoV, and SARS-CoV-2. According to the WHO announcement, the disease caused by SARS-CoV-2 is called COVID-19 (Coronavirus Disease-2019). GLOBAL epidemic of SARS-CoV-2 As of Nov 29, 2021, there have been a total of 260,446,893 reported cases in 195 countries/regions, including 5,207,502 deaths. Since the genetic material of the virus is a single-stranded RNA, which is more likely to mutate while replication. Today, many mutant strains have appeared, include the more infectious variants: the United Kingdom (B.1.1.7), South Africa (B.1.351), Brazil (P.1), and recently reported new mutant strain Omicron (B.1.1.529). Omicron has been listed as a variant of concern (VOC) by the WHO, as of Nov 28, at least 13 countries have reported more than 100 cases.